# An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin

> **NCT07269327** · PHASE1 · COMPLETED · sponsor: **Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany** · enrollment: 24 (actual)

## Conditions studied

- Fertility

## Interventions

- **DRUG:** Desogestrel and ethinylestradiol fixed dose combination
- **COMBINATION_PRODUCT:** Follitropin alfa/lutropin alfa

## Key facts

- **NCT ID:** NCT07269327
- **Lead sponsor:** Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-24
- **Primary completion:** 2026-03-09
- **Final completion:** 2026-03-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07269327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07269327, "An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07269327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*